Literature DB >> 11747871

Comparison of weight increase in users of depot medroxyprogesterone acetate and copper IUD up to 5 years.

L Bahamondes1, S Del Castillo, G Tabares, X E Arce, M Perrotti, C Petta.   

Abstract

The objective of this study was to evaluate retrospectively the weight variation in long-term users of depot medroxyprogesterone acetate (DMPA) compared to users of the TCu380A intrauterine device (IUD). A cohort of 206 healthy women allocated in two groups of 103 women according to the contraceptive method used was evaluated through 5 years. Each user of DMPA was paired with an IUD user by age (+/- 1 year) and weight (+/- 1 kg) at the beginning of the study. Weight was evaluated yearly during 5 years. The mean age at the beginning of the study was 33.1 years in both groups, and the mean weight was 59.4 kg in the IUD users and 60.4 kg in the DMPA group. Both cohorts of women presented significant weight increase at the end of the 5 years of observation (p < 0.001). However, DMPA users presented higher weight increase when compared to IUD users from the second through the fifth year of observation. The DMPA users increased weight by 4.3 kg during the 5 years, and IUD users increased 1.8 kg. In conclusion, DMPA users had a significantly higher weight increase when compared to IUD users. In addition, this cohort of women increased weight throughout the 5 years with the use of DMPA or IUD.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11747871     DOI: 10.1016/s0010-7824(01)00255-4

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  6 in total

1.  Self-perception of weight gain among multiethnic reproductive-age women.

Authors:  Mahbubur Rahman; Abbey B Berenson
Journal:  J Womens Health (Larchmt)       Date:  2011-12-02       Impact factor: 2.681

2.  Long-Term Clinical Outcomes in Diabetic Rhesus Macaques (Macaca mulatta) Treated with Medroxyprogesterone Acetate for Endometriosis.

Authors:  Meghan A Connolly; Mark Trentalange; Caroline J Zeiss
Journal:  Comp Med       Date:  2016       Impact factor: 0.982

3.  Prospective study of weight change in new adolescent users of DMPA, NET-EN, COCs, nonusers and discontinuers of hormonal contraception.

Authors:  Mags E Beksinska; Jenni A Smit; Immo Kleinschmidt; Cecilia Milford; Timothy M M Farley
Journal:  Contraception       Date:  2010-01       Impact factor: 3.375

4.  Early weight gain predicting later weight gain among depot medroxyprogesterone acetate users.

Authors:  Yen-Chi L Le; Mahbubur Rahman; Abbey B Berenson
Journal:  Obstet Gynecol       Date:  2009-08       Impact factor: 7.661

5.  Changes in weight, total fat, percent body fat, and central-to-peripheral fat ratio associated with injectable and oral contraceptive use.

Authors:  Abbey B Berenson; Mahbubur Rahman
Journal:  Am J Obstet Gynecol       Date:  2009-03       Impact factor: 8.661

6.  Weight change among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: Findings from a randomised, multicentre, open-label trial.

Authors:  Mags Beksinska; Rodal Issema; Ivana Beesham; Tharnija Lalbahadur; Katherine Thomas; Charles Morrison; G Justus Hofmeyr; Petrus S Steyn; Nelly Mugo; Thesla Palanee-Phillips; Khatija Ahmed; Gonasagrie Nair; Jared M Baeten; Jenni Smit
Journal:  EClinicalMedicine       Date:  2021-04-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.